Literature DB >> 26100423

Athletes with Implantable Cardioverter Defibrillators.

Shiva P Ponamgi1, Christopher V DeSimone2, Michael J Ackerman3.   

Abstract

Athletes with an implantable cardioverter defibrillator (ICD) represent a diverse group of individuals who may be at an increased risk of sudden cardiac death when engaging in vigorous physical activity. Therefore, they are excluded by the current guidelines from participating in most competitive sports except those classified as low intensity, such as bowling and golf. The lack of substantial data on the natural history of the cardiac diseases affecting these athletes as well as the unknown efficacy of ICDs in terminating life-threatening arrhythmias occurring during intense exercise has resulted in the restrictive nature of these now decade old guidelines.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Athlete; Bethesda Conference; European Society of Cardiology (ESC); Exercise; Implanted cardioverter defibrillator (ICD); Long QT syndrome; Sudden cardiac death

Mesh:

Year:  2015        PMID: 26100423      PMCID: PMC4478445          DOI: 10.1016/j.csm.2015.03.010

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN: 0278-5919            Impact factor:   2.182


  65 in total

1.  An entirely subcutaneous implantable cardioverter-defibrillator.

Authors:  Gust H Bardy; Warren M Smith; Margaret A Hood; Ian G Crozier; Iain C Melton; Luc Jordaens; Dominic Theuns; Robert E Park; David J Wright; Derek T Connelly; Simon P Fynn; Francis D Murgatroyd; Johannes Sperzel; Jörg Neuzner; Stefan G Spitzer; Andrey V Ardashev; Amo Oduro; Lucas Boersma; Alexander H Maass; Isabelle C Van Gelder; Arthur A Wilde; Pascal F van Dessel; Reinoud E Knops; Craig S Barr; Pierpaolo Lupo; Riccardo Cappato; Andrew A Grace
Journal:  N Engl J Med       Date:  2010-05-12       Impact factor: 91.245

Review 2.  Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials.

Authors:  Johannes B van Rees; Mihály K de Bie; Joep Thijssen; C Jan Willem Borleffs; Martin J Schalij; Lieselot van Erven
Journal:  J Am Coll Cardiol       Date:  2011-08-30       Impact factor: 24.094

Review 3.  Sudden cardiac death among competitive adult athletes: a review.

Authors:  Andrew Pugh; John P Bourke; Vijay Kunadian
Journal:  Postgrad Med J       Date:  2012-02-23       Impact factor: 2.401

4.  Return to play? Athletes with congenital long QT syndrome.

Authors:  Jonathan N Johnson; Michael J Ackerman
Journal:  Br J Sports Med       Date:  2012-11-28       Impact factor: 13.800

Review 5.  Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation.

Authors:  Kjetil Isaksen; Ingvild Margreta Morken; Peter Scott Munk; Alf Inge Larsen
Journal:  Eur J Prev Cardiol       Date:  2012-08       Impact factor: 7.804

6.  Competitive sports participation in athletes with congenital long QT syndrome.

Authors:  Jonathan N Johnson; Michael J Ackerman
Journal:  JAMA       Date:  2012-08-22       Impact factor: 56.272

7.  Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.

Authors:  Eleanor B Schron; Derek V Exner; Qing Yao; Louise S Jenkins; Jonathan S Steinberg; James R Cook; Steven P Kutalek; Peter L Friedman; Rosemary S Bubien; Richard L Page; Judy Powell
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

8.  Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.

Authors:  Louise R A Olde Nordkamp; Reinoud E Knops; Gust H Bardy; Yuri Blaauw; Lucas V A Boersma; Johannes S Bos; Peter Paul H M Delnoy; Pascal F H M van Dessel; Antoine H G Driessen; Joris R de Groot; Jean Paul R Herrman; Luc J L M Jordaens; Kirsten M Kooiman; Alexander H Maass; Mathias Meine; Yuka Mizusawa; Sander G Molhoek; Jurjen van Opstal; Jan G P Tijssen; Arthur A M Wilde
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

9.  Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.

Authors:  Christof Kolb; Marcio Sturmer; Peter Sick; Sebastian Reif; Jean Marc Davy; Giulio Molon; Jörg Otto Schwab; Giuseppe Mantovani; Dan Dan; Carsten Lennerz; Alberto Borri-Brunetto; Dominique Babuty
Journal:  JACC Heart Fail       Date:  2014-10-01       Impact factor: 12.035

10.  Reduction in inappropriate therapy and mortality through ICD programming.

Authors:  Arthur J Moss; Claudio Schuger; Christopher A Beck; Mary W Brown; David S Cannom; James P Daubert; N A Mark Estes; Henry Greenberg; W Jackson Hall; David T Huang; Josef Kautzner; Helmut Klein; Scott McNitt; Brian Olshansky; Morio Shoda; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2012-11-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.